secwatch.observer — SEC 8-K summary
======================================

Issuer:     BriaCell Therapeutics Corp. (BCTX)
CIK:        0001610820
Form:       8-K
Filed at:   2024-06-14T23:59:59+00:00
Accession:  0001493152-24-023860
Event type: other_material
Sentiment:  negative
Materiality: 0.65
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BriaPro subsidiary reports $317K net loss, $1 cash, going concern doubt
-----------------------------------------------------------------------

- Net loss of $316,517 for nine months ended April 30, 2024; zero revenue.
- Cash and equivalents of $1; current liabilities $356,734; shareholders' deficit $301,924.
- Going concern warning: dependent on future financing, significant doubt.
- Intangible assets (patents) of $203,614 from August 2023 spin-out from BriaCell.
- Operating loss of $366,960 for the nine-month period, R&D expense $227,249.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1610820/000149315224023860/0001493152-24-023860-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1610820/000149315224023860/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-023860

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer